198 related articles for article (PubMed ID: 37385987)
1. Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression.
Chen Z; Tian D; Chen X; Cheng M; Xie H; Zhao J; Liu J; Fang Z; Zhao B; Bian E
Cell Death Dis; 2023 Jun; 14(6):383. PubMed ID: 37385987
[TBL] [Abstract][Full Text] [Related]
2. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.
Bian E; Chen X; Cheng L; Cheng M; Chen Z; Yue X; Zhang Z; Chen J; Sun L; Huang K; Huang C; Fang Z; Zhao B; Li J
J Exp Clin Cancer Res; 2021 Oct; 40(1):337. PubMed ID: 34696771
[TBL] [Abstract][Full Text] [Related]
3. LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U.
Pan J; Tang Y; Liu S; Li L; Yu B; Lu Y; Wang Y
Cancer Med; 2020 Jun; 9(11):3829-3839. PubMed ID: 32239804
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Yu H; Qi L
J Exp Clin Cancer Res; 2019 Dec; 38(1):486. PubMed ID: 31823805
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
Wu D; Sun J; Wang H; Ma C
Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
Zhou H; Ma Y; Zhong D; Yang L
Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
[TBL] [Abstract][Full Text] [Related]
7. Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686.
Chai Y; Wu HT; Liang CD; You CY; Xie MX; Xiao SW
Int J Nanomedicine; 2020; 15():8863-8872. PubMed ID: 33204092
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/β-catenin signaling pathways.
He L; Yang H; Zhu XL; Zhang Y; Lv K
Brain Res Bull; 2021 Nov; 176():112-120. PubMed ID: 34474120
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
Suo ST; Gong P; Peng XJ; Niu D; Guo YT
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
[TBL] [Abstract][Full Text] [Related]
10. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
Xiao S; Wang R; Wu X; Liu W; Ma S
DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
Gai SY; Yuan ZH
Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
[TBL] [Abstract][Full Text] [Related]
13. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis.
Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
Hum Cell; 2020 Apr; 33(2):416-426. PubMed ID: 32072565
[TBL] [Abstract][Full Text] [Related]
15. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HAND2-AS1 attenuates glioma cell proliferation, invasion and migration by targeting CDK6.
Liu S; Li Y
Neurol Res; 2022 Aug; 44(8):677-683. PubMed ID: 35548927
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Zhang D; Zhou H; Liu J; Mao J
Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
[TBL] [Abstract][Full Text] [Related]
19. LEF1-AS1 accelerates tumorigenesis in glioma by sponging miR-489-3p to enhance HIGD1A.
Cheng Z; Wang G; Zhu W; Luo C; Guo Z
Cell Death Dis; 2020 Aug; 11(8):690. PubMed ID: 32826866
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.
Qin X; Yao J; Geng P; Fu X; Xue J; Zhang Z
Int J Clin Exp Pathol; 2014; 7(6):3065-72. PubMed ID: 25031725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
